Akèy › Edem makile
Etid klinik pou Edem makile ap rekrite nan Etazini
8 etid pou Edem makile ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Austin, TX4 etid
- Hagerstown, MD4 etid
- Carmel, IN3 etid
- Phoenix, AZ3 etid
- Boston, MA3 etid
- Cleveland, OH3 etid
- Denver, CO3 etid
- Nashville, TN3 etid
- Houston, TX3 etid
- The Woodlands, TX3 etid
- Fort Lauderdale, FL3 etid
- Glendale, CA3 etid
- Charleston, SC3 etid
- Eugene, OR3 etid
- Raleigh, NC3 etid
- Pasadena, CA3 etid
- Columbia, SC3 etid
- San Antonio, TX3 etid
Pa eta
- Arizona3 etid
- Colorado4 etid
- Connecticut3 etid
- Florid4 etid
- Indiana3 etid
- Kalifòni4 etid
- Maryland4 etid
- Massachusetts3 etid
- New Jersey3 etid
- New York3 etid
- North Carolina5 etid
- Ohio3 etid
- Oregon3 etid
- Pennsylvania3 etid
- South Carolina5 etid
- Tennessee4 etid
- Texas4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07705607A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07705555A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06962839Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients
Ap rekriteFaz 1
Laj 18 a 65 · Tout sèks · Mizajou Jun 5, 2026 · NCT06395285A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT06996080Therapeutic Contact Lens Drug Delivery System (TCL-DDS) in Patients With Recurrent Cystoid Macular Edema
Ap rekriteFaz 1/2
Laj 18 a 85 · Tout sèks · Mizajou Nov 26, 2025 · NCT04225611Imaging Retinal Vasculature in Infant Eyes
Ap rekriteEtid obsèvasyon
2 Months · Tout sèks · Mizajou Oct 6, 2025 · NCT05558059Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.